|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02315 BIOCYTOGEN-B
Nominal 
60.950 -0.800 (-1.296%) Non-current Assets
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,750,228 | 28.143% | 1,365,842 | 1,349,489 | 1,450,828 | 1,599,079 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 | 0 |
| Intangible Assets | 11,234 | -15.913% | 13,360 | 20,665 | 28,130 | 30,652 |
| Interests in Asso. & JCEs | 116,951 | -14.916% | 137,453 | 159,038 | 188,375 | 197,944 |
| Other Non-current Assets | 60,532 | 2.708% | 58,936 | 69,587 | 59,025 | 52,861 |
| 1,938,945 | 23.061% | 1,575,591 | 1,598,779 | 1,726,358 | 1,880,536 | |
Current Assets
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | 6,231 | -17.426% | 7,546 | 3,890 | 7,416 | 18,604 | |
| Trade Receivables | 313,195 | 4.291% | 300,310 | 229,608 | 142,384 | 107,682 | |
| Cash & Bank Balances | 789,530 | -49.146% | 1,552,556 | 384,458 | 399,607 | 610,882 | |
| Other Current Assets | 594,651 | 106.218% | 288,361 | 198,579 | 173,643 | 182,128 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 1,703,607 | -20.717% | 2,148,773 | 816,535 | 723,050 | 919,296 | ||
Current Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | 116,778 | -14.026% | 135,830 | 115,479 | 175,234 | 146,190 | ||
| S-T Debt & Leases | 56,872 | -74.986% | 227,361 | 225,995 | 203,199 | 171,603 | ||
| Other Current Liabilities | 325,001 | -42.692% | 567,115 | 193,439 | 199,183 | 288,253 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 498,651 | -46.399% | 930,306 | 534,913 | 577,616 | 606,046 | |||
| Net Current Assets | 1,204,956 | -1.109% | 1,218,467 | 281,622 | 145,434 | 313,250 | ||
| Total Assets Less Current Liabilities | 3,143,901 | 12.521% | 2,794,058 | 1,880,401 | 1,871,792 | 2,193,786 | ||
Non-current Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 636,619 | 78.460% | 356,730 | 344,282 | 340,910 | 243,677 | |||
| Other Non-current Liabilities | 81,105 | -68.549% | 257,874 | 697,518 | 740,446 | 799,293 | |||
| 717,724 | 16.778% | 614,604 | 1,041,800 | 1,081,356 | 1,042,970 | ||||
Capital and Reserves
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | 446,898 | 0.000% | 446,898 | 399,398 | 399,398 | 399,398 | ||||
| Reserves | 1,974,735 | 14.278% | 1,728,011 | 434,658 | 386,488 | 746,867 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 2,421,633 | 11.344% | 2,174,909 | 834,056 | 785,886 | 1,146,265 | ||||
| Non-controlling Interests | 4,544 | -0.022% | 4,545 | 4,545 | 4,550 | 4,551 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 2,426,177 | 11.320% | 2,179,454 | 838,601 | 790,436 | 1,150,816 | |||||
Commitments and Contingent Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | 30,797 | 0 | 12,458 | 8,838 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 09/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 241,095 |
| %Change | 402.292% |
| EPS / (LPS) | RMB 0.540 |
| NBV Per Share (¥) | RMB 5.419 |